On the 2nd to 4th March 2021, the IMI-PainCare consortium held its annual General Assembly, conducted as a virtual meeting owed to the Covid-19 pandemic. About half way into the funding period, more than 70 consortium members together with IMI scientific officer Elisabetta Vaudano, the external ethics and scientific advisors, discussed exciting achievements and ongoing activities.